Position in SLS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$447,228
New position
Shares Held
30,300
first reported quarter
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#92
of 187 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in SLS
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$447,228
PutShares
30,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sculptor Capital LP holds $32,206,136 across 10 Biotechnology names. SLS ranks #6 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
350,000 | $24,727,500 | |
| 2 | ABCL |
AbCellera Biologics Inc.
|
454,000 | $3,563,900 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
50,000 | $1,935,000 | |
| 4 | BCYC |
Bicycle Therapeutics PLC
|
197,904 | $839,112 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
79,200 | $693,396 | |
| 6 | SLS |
SELLAS Life Sciences Group, Inc.
This page
|
30,300 | $447,228 | |
| 7 | ASBP |
Aspire Biopharma Holdings, Inc.
|
500,000 | $0 | |
| 8 | OABIW |
OmniAb, Inc.
|
293,802 | $0 |
All Filings in SLS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $447,228 | 30,300 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $447,228 | 30,300 | Put | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||